What is budesonide oral suspension (Eohilia) mainly used to treat?

Budesonide oral suspension (Eohilia) is a medicine specifically indicated to treat eosinophilic esophagitis (EoE) in patients 11 years of age and older. Eosinophilic esophagitis is a chronic, immune-mediated inflammatory disease of the esophagus characterized by symptoms such as dysphagia, retrosternal pain, and food impaction. The core pathological mechanism is abnormal infiltration of eosinophils in the esophageal tissue, triggering a local inflammatory response and thus affecting the function of the esophageal mucosa. Budesonide Oral Suspension relieves symptoms and improves swallowing function by delivering the topical corticosteroid budesonide, which acts directly on the esophageal mucosa to reduce the inflammatory response.

The unique dosage form of budesonide oral suspension is an oral suspension. The drug particles appear in a relatively thin state after shaking, but after swallowing in the mouth and entering the esophagus, the liquid returns to a thicker state, thus increasing the residence time of the drug in the esophageal mucosa. This dosage form design allows budesonide to exert its maximum anti-inflammatory effect locally in the esophagus while reducing systemic absorption, thereby reducing the risk of systemic side effects. This is particularly important in the long-term management of patients with eosinophilic esophagitis, which often requires ongoing pharmacological intervention to maintain symptomatic remission.

Clinical application shows that budesonide oral suspension can not only improve patients' swallowing function, but also significantly reduce the esophageal inflammation index, thereby reducing the risk of esophageal structural complications in long-term treatment. Overseas guidelines recommend budesonide oral suspension as the first choice topical corticosteroid treatment for eosinophilic esophagitis, especially in patients who have failed to respond to dietary intervention or other non-pharmacological treatments.

In addition, budesonide oral suspension also has good safety and tolerability, and can be used by children and adolescent patients under the guidance of physicians, thereby improving the quality of life while maintaining long-term treatment safety.

Reference materials:https://www.eohilia.com/